Global Sterile Intravenous (IV) Solution Market Growth (Status and Outlook) 2025-2031

According to this study, the global Sterile Intravenous (IV) Solution market size will reach US$ million by 2031.

Sterile Intravenous (IV), also known as sterile Intravenous therapy is a therapy that delivers liquid which is in medical use into a vein.

United States market for Sterile Intravenous (IV) Solution is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Sterile Intravenous (IV) Solution is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Sterile Intravenous (IV) Solution is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Sterile Intravenous (IV) Solution players cover B. Braun Medical Inc., Technoflex, Baxter International, ICU Medical, Inc, Mckesson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Sterile Intravenous (IV) Solution Industry Forecast” looks at past sales and reviews total world Sterile Intravenous (IV) Solution sales in 2024, providing a comprehensive analysis by region and market sector of projected Sterile Intravenous (IV) Solution sales for 2025 through 2031. With Sterile Intravenous (IV) Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sterile Intravenous (IV) Solution industry.

This Insight Report provides a comprehensive analysis of the global Sterile Intravenous (IV) Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sterile Intravenous (IV) Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sterile Intravenous (IV) Solution market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sterile Intravenous (IV) Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sterile Intravenous (IV) Solution.

This report presents a comprehensive overview, market shares, and growth opportunities of Sterile Intravenous (IV) Solution market by product type, application, key players and key regions and countries.

Segmentation by Type:
Crystalloids
Colloids
Others

Segmentation by Application:
Medications
NutritionNutrition
Blood-based Products
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
B. Braun Medical Inc.
Technoflex
Baxter International
ICU Medical, Inc
Mckesson
Amsino
Wallcur
Hebei Guangren Pharmaceutical Technology
Jiangsu Hengfengqiang Biotechnology
Hospira
Jiangsu Hengfengqiang Biotechnology
Hospira
Xi'an Libang Alliance Enterprise Management
Livzon Group

Please note: The report will take approximately 2 business days to prepare and deliver. Show more